Trial
NCT07025564
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Phase ISUSPENDEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Recurrent Acute Myeloid Leukemia
Intervention
Biospecimen Collection
Why stopped
Pending Interim Analysis
Provenance
Dataset: 2026-07-17 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-14